JPWO2022051591A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022051591A5
JPWO2022051591A5 JP2023514862A JP2023514862A JPWO2022051591A5 JP WO2022051591 A5 JPWO2022051591 A5 JP WO2022051591A5 JP 2023514862 A JP2023514862 A JP 2023514862A JP 2023514862 A JP2023514862 A JP 2023514862A JP WO2022051591 A5 JPWO2022051591 A5 JP WO2022051591A5
Authority
JP
Japan
Prior art keywords
seq
nectin
set forth
cdr1
cdr2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023514862A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023540526A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/049014 external-priority patent/WO2022051591A2/en
Publication of JP2023540526A publication Critical patent/JP2023540526A/ja
Publication of JPWO2022051591A5 publication Critical patent/JPWO2022051591A5/ja
Pending legal-status Critical Current

Links

JP2023514862A 2020-09-04 2021-09-03 ネクチン-4抗体およびそれの使用 Pending JP2023540526A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063074864P 2020-09-04 2020-09-04
US63/074,864 2020-09-04
US202163166622P 2021-03-26 2021-03-26
US63/166,622 2021-03-26
PCT/US2021/049014 WO2022051591A2 (en) 2020-09-04 2021-09-03 Nectin-4 antibodies and uses thereof

Publications (2)

Publication Number Publication Date
JP2023540526A JP2023540526A (ja) 2023-09-25
JPWO2022051591A5 true JPWO2022051591A5 (enExample) 2024-09-09

Family

ID=78080439

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023514862A Pending JP2023540526A (ja) 2020-09-04 2021-09-03 ネクチン-4抗体およびそれの使用

Country Status (7)

Country Link
US (1) US20230331867A1 (enExample)
EP (1) EP4208259A2 (enExample)
JP (1) JP2023540526A (enExample)
KR (1) KR20230060509A (enExample)
AU (1) AU2021337687A1 (enExample)
CA (1) CA3193584A1 (enExample)
WO (1) WO2022051591A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230037502A (ko) * 2020-05-20 2023-03-16 바이사이클티엑스 리미티드 넥틴-4에 특이적인 바이사이클릭 펩티드 리간드 및 이의 용도
AU2022335573C1 (en) 2021-08-27 2026-02-19 CSPC Megalith Biopharmaceutical Co., Ltd. Anti-nectin-4 antibody, drug conjugate, and preparation method therefor and use thereof
CN116063498A (zh) * 2022-04-27 2023-05-05 博际生物医药科技(杭州)有限公司 单域抗Nectin-4抗体
KR20250017209A (ko) * 2022-05-25 2025-02-04 이나뜨 파르마 에스.에이. 넥틴-4 결합제
CA3262070A1 (en) * 2022-07-14 2025-06-13 Bio-Thera Solutions, Ltd. ANTI-NECTIN-4 ANTIBODIES AND THEIR USES
CN120239708A (zh) * 2022-09-20 2025-07-01 耐科廷疗法有限公司 针对黏连蛋白4的人源化抗体及其药物偶联物
JP7689606B2 (ja) * 2023-06-20 2025-06-06 イーライ リリー アンド カンパニー ネクチン-4抗体及び抗体-薬物コンジュゲート
KR20250177512A (ko) * 2024-06-14 2025-12-24 삼성바이오에피스 주식회사 신규한 항-넥틴-4 항체 및 이의 용도

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4737456A (en) 1985-05-09 1988-04-12 Syntex (U.S.A.) Inc. Reducing interference in ligand-receptor binding assays
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
US6548640B1 (en) 1986-03-27 2003-04-15 Btg International Limited Altered antibodies
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
IL162181A (en) 1988-12-28 2006-04-10 Pdl Biopharma Inc A method of producing humanized immunoglubulin, and polynucleotides encoding the same
FR2646437B1 (fr) 1989-04-28 1991-08-30 Transgene Sa Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant
US6075181A (en) 1990-01-12 2000-06-13 Abgenix, Inc. Human antibodies derived from immunized xenomice
US6150584A (en) 1990-01-12 2000-11-21 Abgenix, Inc. Human antibodies derived from immunized xenomice
US5264618A (en) 1990-04-19 1993-11-23 Vical, Inc. Cationic lipids for intracellular delivery of biologically active molecules
AU7979491A (en) 1990-05-03 1991-11-27 Vical, Inc. Intracellular delivery of biologically active substances by means of self-assembling lipid complexes
US6300129B1 (en) 1990-08-29 2001-10-09 Genpharm International Transgenic non-human animals for producing heterologous antibodies
ES2108048T3 (es) 1990-08-29 1997-12-16 Genpharm Int Produccion y utilizacion de animales inferiores transgenicos capaces de producir anticuerpos heterologos.
AU2235992A (en) 1991-06-14 1993-01-12 Genpharm International, Inc. Transgenic immunodeficient non-human animals
EP0940468A1 (en) 1991-06-14 1999-09-08 Genentech, Inc. Humanized antibody variable domain
JPH06508880A (ja) 1991-07-08 1994-10-06 ユニバーシティ オブ マサチューセッツ アット アムハースト サーモトロピック液晶セグメント化ブロックコポリマー
JPH08509612A (ja) 1993-04-26 1996-10-15 ジェンファーム インターナショナル インコーポレイテッド 異種抗体を産生することができるトランスジェニック非ヒト動物
AU760562B2 (en) 1997-12-05 2003-05-15 Scripps Research Institute, The Humanization of murine antibody
IL147765A0 (en) 1999-07-29 2002-08-14 Medarex Inc HUMAN MONOCLONAL ANTIBODIES TO HER2/neu
US7271240B2 (en) 2001-03-14 2007-09-18 Agensys, Inc. 125P5C8: a tissue specific protein highly expressed in various cancers
US20040081653A1 (en) 2002-08-16 2004-04-29 Raitano Arthur B. Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer
RU2386638C2 (ru) 2004-03-31 2010-04-20 Дженентек, Инк. Гуманизированные анти-тфр-бета-антитела
AR066476A1 (es) 2007-05-08 2009-08-19 Genentech Inc Anticuerpos anti-muc16 disenados con cisteina y conjugaods de anticuerpos y farmacos
CA2698541C (en) 2007-10-19 2018-01-09 Genentech, Inc. Cysteine engineered anti-tenb2 antibodies and antibody drug conjugates
MX336540B (es) 2010-06-08 2016-01-22 Genentech Inc Conjugados y anticuerpos manipulados geneticamente con cisteina.
MX347954B (es) 2010-09-29 2017-05-19 Agensys Inc Conjugados de anticuerpo farmaco (adc) que enlazan a proteinas 191p4d12.
CN102469482A (zh) 2010-11-12 2012-05-23 中兴通讯股份有限公司 一种广播控制信道信息倒换方法及系统
EP2729898A1 (en) 2011-07-10 2014-05-14 Blendology Limited An electronic data sharing device and method of use
US20140283153A1 (en) 2011-10-28 2014-09-18 Trianni, Inc. Transgenic animals and methods of use
EP2793947B1 (en) 2011-12-23 2021-02-03 Innate Pharma Enzymatic conjugation of polypeptides
HK1208216A1 (en) 2012-05-15 2016-02-26 Concortis Biosystems, Corp Drug-conjugates, conjugation methods, and uses thereof
ES2718478T3 (es) 2012-06-08 2019-07-02 Sutro Biopharma Inc Anticuerpos que comprenden restos de aminoácidos no naturales de localización específica, métodos para su preparación y métodos para su uso
NO2789793T3 (enExample) 2012-10-24 2018-01-27
US10036010B2 (en) 2012-11-09 2018-07-31 Innate Pharma Recognition tags for TGase-mediated conjugation
EP3010547B1 (en) 2013-06-20 2021-04-21 Innate Pharma Enzymatic conjugation of polypeptides
CN105517577A (zh) 2013-06-21 2016-04-20 先天制药公司 多肽的酶促偶联
EP2845550B1 (de) 2013-09-10 2017-03-29 Erbe Elektromedizin GmbH Chirurgisches Instrument mit Kunststoffschaft
WO2015191883A1 (en) 2014-06-12 2015-12-17 Dophen Biomedical Homogenous antibody drug conjugates via enzymatic methods
SI3185908T1 (sl) 2014-08-28 2020-08-31 Pfizer Inc. Linkerji za modulacijo stabilnosti, ki se uporabljajo s konjugati zdravil s protitelesi
CN108289964B (zh) 2015-08-10 2022-08-12 杭州多禧生物科技有限公司 新型连接体及其用于药物和生物分子的特异性偶联
US20180230238A1 (en) 2015-08-24 2018-08-16 Trianni, Inc Enhanced production of immunoglobulins
JP6985252B2 (ja) * 2015-09-09 2021-12-22 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル ネクチン−4に対する特異性を有する抗体及びその使用
CN108472386A (zh) 2015-10-02 2018-08-31 百时美施贵宝公司 用于缀合抗体的转谷氨酰胺酶变体
SG11201810591VA (en) * 2016-05-27 2018-12-28 Abbvie Biotherapeutics Inc Bispecific binding proteins binding an immunomodulatory protein and a tumor antigen
WO2018140590A1 (en) 2017-01-25 2018-08-02 Massachusetts Institute Of Technology Seft-labeling miniproteins and conjugates comprising them
WO2018158398A1 (en) * 2017-03-02 2018-09-07 INSERM (Institut National de la Santé et de la Recherche Médicale) Antibodies having specificity to nectin-4 and uses thereof
EP3606922A4 (en) 2017-04-06 2021-03-03 Hangzhou Dac Biotech Co., Ltd CONJUGATION OF A CYTOSTATIC WITH BIS CONNECTION
MX2019014318A (es) * 2017-06-05 2020-08-13 Agensys Inc Proteinas de union a nectina-4 y metodos de uso de las mismas.
JP6633247B1 (ja) 2018-05-07 2020-01-22 和寛 檜山 診断情報提供装置、方法及びシステム
CA3097679A1 (en) 2018-05-09 2019-11-14 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Antibodies specific to human nectin4

Similar Documents

Publication Publication Date Title
TWI777056B (zh) 結合至ssea4的單株抗體及其用途
JP2025160458A5 (enExample)
JPWO2020114480A5 (enExample)
JP2019527553A5 (enExample)
JP2019513018A5 (enExample)
JP2018516853A5 (enExample)
JP2013502913A5 (enExample)
JP2024001073A5 (enExample)
JP2024016024A5 (enExample)
JP2020522488A5 (enExample)
CN111712521A (zh) Cd38蛋白抗体及其应用
IL250289B2 (en) Antibodies against angiopoietin-like 4 and methods of use
CN115461373A (zh) 密蛋白18.2的抗体及其用途
JP2020518243A5 (enExample)
JP2023182689A5 (enExample)
JPWO2022051591A5 (enExample)
CN114829405A (zh) 抗bcma/抗4-1bb双特异性抗体及其用途
JPWO2022114163A5 (enExample)
CN112805297B (zh) 抗人类pd-l1抗体及其用途
JPWO2022067262A5 (enExample)
JP2026506070A (ja) 抗cntn4抗体及びその使用
JPWO2022207822A5 (enExample)
JPWO2022159984A5 (enExample)
JPWO2021068841A5 (enExample)
JPWO2020076790A5 (enExample)